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Smad10 Is Required for Formation
of the Frog Nervous System
cascade (Chevet et al., 1999; Demo et al., 1994; Ribisi et
al., 2000). In Xenopus, FGF is secreted by the organizer,
induces neural tissue of posterior character, and is re-
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induction (Streit et al., 2000).
Smads transduce TGF superfamily (including BMP)
signals and can function as transcription factors (PiekSummary
et al., 1999). The Smad family can be divided into three
categories: receptor-regulated Smads (R-Smads; Smad1,Before the nervous system establishes its complex
array of cell types and connections, multipotent cells Smad2, Smad3, Smad5, and Smad8), common Smads
(co-Smads; Smad4), and antagonistic Smads (Smad6are instructed to adopt a neural fate and an anterior-
posterior pattern is established. In this report, we and Smad7) (Heldin et al., 1997). R-Smads function
downstream of specific subsets of TGF ligand-recep-show that Smad10, a member of the Smad family of
intracellular transducers of TGF signaling, is required tor complexes to transduce their signal into the nucleus.
This process is thought to depend on phosphorylationfor formation of the nervous system. In addition, two
types of molecules proposed as key to neural induction of R-Smads on a cluster of serines at their carboxyl
terminus, by a TGF superfamily serine kinase receptorand patterning, bone morphogenetic protein (BMP) an-
tagonists and fibroblast growth factor (FGF), require complex (Derynck and Zhang, 1996; Heldin et al., 1997;
Hill, 1999; Massague, 1996; Piek et al., 1999; Wrana andSmad10 for these activities. These data suggest that
Smad10 may be a central mediator of the development Attisano, 1996; Zhang et al., 1996). After phosphoryla-
tion, the Smads dissociate from the receptors and trans-of the frog nervous system.
locate from the cytosol to the nucleus where they bind
DNA and regulate gene expression. The co-Smad, Smad4,Introduction
associates with R-Smads and is not thought to be re-
stricted to any specific TGF signaling pathway. Smad10,Over 75 years ago, Spemann and Mangold first defined
neural induction in the amphibian embryo (Hamburger, also termed XSmad4, is a recently described Smad that
is most structurally similar to Smad4 (65% identity).1988; Spemann, 1938). They demonstrated that a small
piece of dorsal mesoderm, transplanted to the ventral Several groups have characterized Smad10 (XSmad4)
through gain-of-function studies (Howell et al., 1999;side of a host embryo, instructs host epidermal tissues
to change fate and form a complete nervous system LeSueur and Graff, 1999; Masuyama et al., 1999). Al-
though the studies were all done in Xenopus, different(Harland and Gerhart, 1997; Sasai and De Robertis,
1997; Spemann, 1938). In addition, the transplant repat- developmental roles were proposed for Smad10 includ-
ing formation of anterior and posterior neural tissue,terns ventral tissues to more dorsal fates such as heart
and kidney (Harland and Gerhart, 1997). The region re- induction of mesoderm, and patterning of mesoderm.
In part, the different results may be due to differencessponsible for these activities is termed the Spemann
organizer and its homolog in the mouse and chick is in experimental approaches and to the potential artifacts
inherent in sufficiency tests. To determine the endoge-termed the node (Harland and Gerhart, 1997; Sasai and
De Robertis, 1997). nous roles of Smad10, we undertook loss-of-function
approaches.In the last decade, a host of neural-inducing, organi-
zer-secreted molecules was uncovered. One group of
molecules includes noggin, chordin, follistatin, Xnr3, Results
Cerberus, and Gremlin, all of which induce anterior neu-
ral tissue by blocking epidermal-inducing BMP signals Smad10 and Smad4 Are Distinct
(Bouwmeester et al., 1996; Hansen et al., 1997; Harland First, we attempted to determine whether the two related
and Gerhart, 1997; Hemmati-Brivanlou et al., 1994; Hem- Smads (4 and 10) have distinct functional properties and
mati-Brivanlou and Melton, 1997; Hsu et al., 1998; Lamb et we tried to identify domains or interacting partners that
al., 1993; Piccolo et al., 1996; Sasai et al., 1995; Sasai and might contribute to any potential differences in activity.
De Robertis, 1997; Zimmerman et al., 1996). Such BMP Animal cap cells are normally fated to become epidermal
antagonism is required for normal forebrain develop- tissue but can be converted to endoderm, different types
ment, as revealed by compound mutant mice with dis- of mesoderm, or neural tissue, depending upon which
ruptions in both noggin and chordin (Bachiller et al., signal is transduced. To assess Smad4 and Smad10
2000). Recent evidence also points to a key role for function, we microinjected mRNA encoding them and
FGF, which signals via a receptor tyrosine kinase (RTK) analyzed the resultant animal cap explants for expres-
sion of molecular markers (Figure 1A). Smad10 did not
induce mesodermal markers but did induce the expres-1Correspondence: jon.graff@utsouthwestern.edu
2 Co-first authors. sion of NCAM, a marker of neural tissue. In contrast,
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Figure 1. Smad10 and Smad4 Are Distinct
(A) Synthetic mRNA encoding Smad4, Smad10, Smad4/10/4, Smad10/4/10, Smad4-C, and Smad10-C (4 ng) was injected into one-cell embryos,
and animal caps were analyzed for expression of molecular markers by RT-PCR. The lane marked Embryo contains total RNA from whole
embryos; RT is identical to Embryo except that reverse transcriptase (RT) was omitted; EF-1, a ubiquitously expressed message, is a
loading control (Krieg et al., 1989).
(B) mRNA encoding GST-Hesr-1 (6 ng), myc-Smad10 (1 ng), and myc-Smad4 (1 ng) were injected into one-cell embryos and a GST pull-down
assay was performed.
(C) Animal caps expressing Hesr-1 (1 ng) were evaluated by RT-PCR.
(D) Synthetic mRNA encoding DNS10 (4 ng) or Smad10 (S10, 4 ng) was injected into one-cell embryos alone or together and animal caps
were analyzed by RT-PCR.
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Smad4 induced the expression of the ventral mesoder- Smad1, Smad2, and Smad4 Do Not Require
Smad10 for Functionmal marker globin, but not muscle actin, a marker of
dorsal mesoderm, nor NCAM. Next, we determined To determine the endogenous role of Smad10 in Xenopus,
we turned to two distinct tests of necessity: dominantwhether these marked functional differences were also
detectable in the carboxyl MH2 region, which contains inhibitory forms of Smad10 and morpholino oligonucleo-
tides to block Smad10 translation. In one approach, wethe activation domain. Of note, when this domain is
expressed for the R-Smads, all induce expression of attempted to generate an inhibitory form of Smad10
(DNS10) and fused a nuclear localization signal and themuscle actin, most losing wild-type specificity (Fortuno
et al., 2001). Smad10C also induced muscle actin ex- engrailed transcriptional repressor domain (EnR) to the
MH1 domain and linker of Smad10 (Jaynes and O’Farrell,pression; however, Smad4C did not (Figure 1A).
We extended the structural comparison through chi- 1991; Piek et al., 1999). To determine whether DNS10
would inhibit Smad10 activity, we assessed its functionmeric analyses. Smads are thought to contain three dis-
tinct regions, the amino MH1 domain, the middle linker in the animal cap assay. In this assay, Smad10 induced
the expression of the general neural marker NCAM asdomain, and the carboxyl MH2 domain; so, we made
chimeras swapping all three domains between Smad10 well as markers of the forebrain (otx2), midbrain/hind-
brain junction (En-2), hindbrain (krox20), and spinal cordand Smad4 (Figure 1A). Smad4/10/4 was active and
induced globin expression similar to wild-type Smad4. (HoxB9) (Bradley et al., 1993; Hemmati-Brivanlou et al.,
1991; Lamb and Harland, 1995; Wright et al., 1990; FigureThe Smad10/4/10 chimera was also active, and like
Smad10, it induced NCAM. No other chimera reproduci- 1D). In contrast, when expressed alone, DNS10 had no
detectable activity (Figure 1D). Yet, DNS10 diminishedbly induced gene expression; however, Smad4/4/10 and
Smad4/10/10 displayed morphological changes. These the ability of Smad10 to induce the expression of neural
markers (Figure 1D), indicating that DNS10 might blockdata suggested that the specificity was contained in
the MH1 and MH2 domains. However, unlike wild-type Smad10 activity in whole embryos. Of note, constructs
of Smad10 that were identical to DNS10, except for theSmad10, Smad10/4/10 caps had prominent cement
glands, which indicate anterior neural fates (not shown). EnR domain, did not block Smad10 activity (not shown),
suggesting that DNS10 might function by blockingConsistent with that, wild-type Smad10 induced the
posterior spinal cord marker HoxB9, while Smad10/4/ Smad10-dependent transcription.
To further address specificity, we examined whether10 did not (Figure 1A). In sum, these data support the
notion that the differences of primary structure between DNS10 would alter the activity of other Smads. We also
generated an equivalent construct with Xenopus Smad4Smad4 and Smad10 account for their functional unique-
ness and suggest that, in addition to the MH2 domain, (DNXS4) as a specificity control. As Smad4 is a common
mediator of Smad activity, DNXS4 should block thethe linker and MH1 domains might contain specificity.
One possible explanation for the different transcrip- function of many Smads. As expected of a molecule that
should block Smad1 and, thus, BMP activity, DNXS4tional responses is that Smad4 and Smad10 associate
with distinct subsets of transcription factors. No tran- induced NCAM expression (Figure 1E). This is quite dis-
tinct from DNS10, which blocked NCAM expression (Fig-scription factors had yet been identified that bound to
Smad10. So, we performed a yeast two-hybrid screen ure 1D).
Next, we analyzed the activity of XSmad4 in the pres-with Smad10 as bait. One of four positives was Hesr-1
(for hairy and enhancer of split related-1), a member of ence of either DNS10 or DNXS4. XSmad4 induced the
ventral mesodermal marker globin; DNXS4 eliminateda family of transcription factors that, in some organisms,
controls cell fate decisions including neural develop- this induction, but DNS10 did not (Figure 1E). DNS10
did diminish globin expression, possibly secondary toment (Fisher and Caudy, 1998; Kokubo et al., 1999). In
GST pull-downs, Smad10, but not Smad4, bound Hesr-1 effects on the Smad complex or nonspecifically via in-
creased RNA concentration. We also tested whether(Figure 1B), although at higher doses the specificity was
reduced. In the animal cap assay, Hesr-1 induced the DNS10 or DNXS4 would alter Smad2 function. As de-
scribed, Smad2 induced muscle actin expression (Graffexpression of the anterior neural markers XAG and otx2,
but not the posterior neural marker HoxB9 or the meso- et al., 1996). While DNXS4 blocked this activity, DNS10
had no effect (Figure 1F). Of note, when the DNXS4-dermal marker M. actin (Figure 1C; Bradley et al., 1993;
Hemmati-Brivanlou et al., 1991; Lamb and Harland, or DNS10-injected embryos were allowed to develop
without any further manipulations, they displayed mark-1995; Wright et al., 1990). Thus, Smad10 may act in
concert with Hesr-1 to form anterior neural tissue. edly different phenotypes. The phenotype of the DNS10
(E) Animal caps expressing DNS10 (4 ng), Smad10 (4 ng), DNS10 with Smad10, DNXS4 (500 pg), XSmad4 (4 ng), XSmad4 with DNXS4, and
XSmad4 with DNS10 were analyzed by RT-PCR.
(F) DNS10 (4 ng), DNXS4 (500 pg), Smad2 (1 ng), Smad2 with DNS10, or Smad2 with DNXS4 were injected for the animal cap assay and
analyzed by RT-PCR.
(G) Animal caps expressing Smad1 (4 ng), Smad2 (1 ng), or Smad4 (4 ng) with or without Smad10 MO (5 ng) were assessed by RT-PCR.
(H) Two-cell embryos were injected into the animal pole of both blastomeres with -galactosidase mRNA (-gal, 4 ng/cell), DNS10 mRNA (4
ng/cell), control MO (C MO, 5 ng/cell), or with morpholino directed against Smad10 (S10 MO, 5 ng/cell). For the rescue experiments, DNS10
mRNA (4 ng/cell) or Smad10 MO (S10 MO, 35 ng/cell) was coinjected with Smad10 mRNA. The phenotypes were highly penetrant (80%) in
multiple experiments (n  5).
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embryos will be described in detail below. The DNXS4- with reflex) were similar to those obtained with the mor-
pholinos, which is consistent with the idea that the ef-injections produced animals that resembled “bubble
fects are specific.embryos” (not shown), indicative of a lack of mesoderm
(Hemmati-Brivanlou and Melton, 1992), which supports
Smad10 Is Required for Formationthe idea that Smad4 is the key co-Smad for mesoderm
of the Nervous Systeminduction.
To further study the phenotype produced by loss ofGiven the potential problems with dominant inhibitory
Smad10 activity, we analyzed histological sections andconstructs, we also attempted a separate and distinct
found that the notochord, somites (mesodermal deriva-approach to study loss of Smad10 function in embryos.
tives), and the neural tube were normal in control MO-To that end, we synthesized an antisense, morpholino-
injected embryos (Figure 2A). We observed similar re-modified oligonucleotide (morpholinos or MO) targeted
sults with -galactosidase-injected embryos (not shown).to Smad10 (Smad10 MO). Morpholinos block translation
Strikingly, while the notochord and somites were stillwith high specificity; this has been demonstrated in vitro,
present, the neural tube was eliminated in Smad10 MO-in tissue culture, in zebrafish, and in Xenopus (Heasman
and DNS10-injected embryos (Figure 2A). These dataet al., 2000; Nasevicius and Ekker, 2000; Summerton,
suggest that Smad10 is required for formation of the1999). In both Xenopus and zebrafish, morpholinos have
neural tube but not mesodermal structures. These re-recapitulated known loss-of-function and mutant phe-
sults were confirmed by in situ hybridizations (Figurenotypes (Heasman et al., 2000; Nasevicius and Ekker,
2B) and RT-PCR (Figure 2C) for NRP-1 or NCAM (general2000). Smad10 had been proposed to function in a com-
neural markers; Lamb and Harland, 1995) and muscleplex with Smad1, Smad2, and Smad4. However, Smad10
actin (dorsal mesoderm; Mohun et al., 1984). We alsoMO, which is active (see below), did not inhibit the ability
coinjected the Smad10 morpholino with Smad10 andof Smad1, Smad2, or Smad4 to induce mesoderm in
found that Smad10 rescued neural induction in Smad10the animal cap assay (Figure 1G). Taken together, these
MO embryos (Figure 2C).data suggest that we have two approaches, DNS10 and
Next, we examined regionally specific neural markers.Smad10 MO, to specifically examine the endogenous
In situ hybridizations revealed that decreasing Smad10role of Smad10.
activity eliminated forebrain (otx2), midbrain/hindbrain
(En-2), and spinal cord (HoxB9) formation (Figure 3A).
We also noted that melanocytes, a neural crest deriva-Smad10 Is Required for Normal Development
tive (Anderson, 1997; Nieuwkoop and Faber, 1967), wereTo assess the endogenous role of Smad10, we inhibited
absent in the majority of Smad10 MO-injected embryosits function by injecting either Smad10 MO or mRNA
(Figure 3B). Five percent (2 of 37) of Smad10 MO em-encoding DNS10 into Xenopus embryos and allowed
bryos had melanocytes, compared to 91% (102 of 112)them to develop without further perturbations. As con-
of control MO embryos. Thus, Smad10 activity is re-trols, we injected -galactosidase mRNA (-gal), a non-
quired for formation of the nervous system, and at leastspecific morpholino designed by Gene Tools (control
some of the neural crest.MO), and a morpholino targeted to casein kinase I epsi-
To further characterize the status of paraxial meso-lon (CKI MO), a component of the Wnt pathway (McKay
derm and early neural tissue in embryos with reducedet al., 2001; Peters et al., 1999).-gal and control MO had
Smad10 activity, we performed whole-mount in situ hy-no visible effect on embryogenesis (Figure 1H). Embryos
bridization on early neurula embryos (Figure 3C). In em-injected with CKI MO were shorter than and bent com-
bryos injected with Smad10 MO, the domain of expres-pared to control embryos, but appeared otherwise nor-
sion of MyoD, a marker of somites (Hopwood et al.,mal (not shown), consistent with a blockade of Wnt sig-
1989), was slightly reduced when compared with con-
naling (McKay et al., 2001; Sokol, 1996). Of note, both
trol, uninjected embryos. We also examined the expres-
DNS10 and Smad10 MO produced a similar and distinct
sion of X-ngnr-1b, a proneural gene (Ma et al., 1996), and
phenotype in which the embryos were shorter and found that it was undetectable in Smad10 MO embryos
rounder than controls and appeared to lack normal head (data not shown), just like the late neural markers (Fig-
structures (Figure 1H). To determine whether DNS10 ures 2 and 3). Next, we analyzed the expression of Sox-2,
and Smad10 MO were specifically blocking Smad10, an early, pan-neural marker (Mizuseki et al., 1998). Sox-2
we performed rescue experiments with Smad10 mRNA levels were significantly reduced in Smad10 MO em-
(Heasman et al., 2000; Hudson et al., 1997; Nasevicius bryos compared to controls. The concomitant decrease
and Ekker, 2000). Of note, Smad10 mRNA, which lacks in the size of both the early somitic mesoderm and neural
the 5 UTR to which most of the morpholino was de- plate is consistent with the recent report from Harland’s
signed, rescued both the Smad10 MO-dependent and group (Mariani et al., 2001). Of note, Sox-2 is the first
the DNS10 mRNA-dependent phenotypes (Figure 1H). example of a gene that was expressed in control neural
Xenopus embryos exhibit a reflex movement when tissue and was still detectable in Smad10-depleted em-
touched (Nieuwkoop and Faber, 1967). Although greater bryos. One possible explanation was that the initial
than 97% of uninjected and control MO-injected em- phase of Sox-2 expression is autonomous of the orga-
bryos had a normal reflex, only 17% of Smad10 MO- nizer. To evaluate that notion, we examined the expres-
injected embryos exhibited a reflex. Again, Smad10 sion of Sox-2 in ectodermal explants that were isolated
mRNA rescued the Smad10 MO phenotype, restoring at stage 8.5, prior to formation of the organizer. We
reflex to 93% of embryos. Results with -galactosidase found that Sox-2 is present in this tissue, which is destined
to an epidermal fate, at stages 8.5, 12.5, and 15 (Figure3D).(no change in % with reflex) and DNS10 mRNA (20%
Smad10 Is Required for Nervous System Formation
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Figure 2. Smad10 Is Required for Formation of the Nervous System
(A) Control MO (C MO, 5 ng/cell), Smad10 MO (S10 MO, 5 ng/cell), or DNS10 mRNA (4 ng/cell) were injected into the animal pole of both
blastomeres of two-cell embryos. At stage 35, embryos were processed for histology and hematoxylin and eosin staining. NC, notochord;
NT, neural tube; PE, pharyngeal endoderm.
(B) Two-cell embryos were injected with 5 ng of morpholino or 4 ng of mRNA into the animal pole of each blastomere and then analyzed by
whole-mount in situ hybridization for expression of the general neural marker NRP-1 (Knecht et al., 1995) and the mesodermal marker muscle
actin (MA; Mohun et al., 1984).
(C) Animal caps from embryos injected with control MO, Smad10 MO, and Smad10 MO with Smad10 mRNA (1 ng/cell, rescue) were analyzed
by RT-PCR. U, uninjected; , no RT. The phenotypes were highly penetrant (80%) in multiple experiments (n  5).
To determine the fate of those cells that normally Smad10 Is Required for Cardiogenesis
and Nephrogenesiswould become neural, we injected morpholinos (control
or Smad10), and then at the 32-cell stage, injected The organizer is important not only in formation of the
nervous system, but is also required for heart and kidney-galactosidase mRNA as a lineage tracer into the B1
cells, whose descendents most frequently populate the development (Harland and Gerhart, 1997). Sufficiency
tests had revealed that Smad10 mimics multiple Spe-nervous system (Dale and Slack, 1987). We allowed the
embryos to develop and examined the location of the mann organizer functions, including neural induction
and dorsalization (LeSueur and Graff, 1999). As neces--galactosidase-expressing cells. Seventy-six percent
of control MO embryos expressed -galactosidase in sity tests had shown the importance of Smad10 in neural
development, Smad10 might also be important in otherthe nervous system (48 of 63; Figure 3E). In Smad10-
depleted embryos, the descendants of the B1 cells were organizer activities. In support of that, the in situ hybrid-
izations with muscle actin showed that, while theprimarily (75%) found in the outer surface of the em-
bryo (Figure 3E). Thus, it appears that in the absence of Smad10 morpholino did not affect formation of somitic
muscle, it appeared to block heart development (Fig-Smad10 activity, cells normally predisposed to become
neural might adopt an epidermal fate. However, a previ- ures 2B and 4A), which requires the organizer (Harland
and Gerhart, 1997). Next, we analyzed the expression ofous study reducing Sox-2 activity found cells fated to
become neural were in a similar location to those lacking NKX2.5, a marker of heart specification (Tonissen et al.,
1994), in morpholino-injected embryos. While controlSmad10, yet they did not appear to be epidermal cells
(Kishi et al., 2000). MO had no effect, Smad10 MO reduced the expression
Developmental Cell
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Figure 3. Smad10 Is Required for Expression of Anterior and Posterior Neural Markers and for Formation of Melanocytes
(A) Embryos were injected and analyzed by in situ hybridization as in Figure 2B.
(B) Albino embryos (albino mother, pigmented father) were examined for the appearance of melanocytes (MC; dark cells visible in the C MO
embryo).
(C) Embryos were injected and analyzed at early neurula by in situ hybridization as in Figure 2B, except that 12.5 ng of morpholino was
injected per cell.
(D) Animal caps were explanted at stage 8.5, prior to organizer signaling, and Sox-2 expression was analyzed by RT-PCR.
(E) Two-cell embryos were injected with morpholinos and, at the 32-cell stage, -galactosidase mRNA was injected into the B1 blastomere.
At stage 27, the embryos were stained with X-gal (blue).
of NKX2.5 (Figure 4B). We also examined nephrogenesis to be key to neural induction and anterior-posterior pat-
through analysis of WT-1, a kidney-specific marker (Car- terning. In Xenopus, FGFs induce posterior neural tis-
roll and Vize, 1996), and found that Smad10 MO greatly sue, and FGFs are required for neural induction in the
inhibited WT-1 expression (Figure 4B). Thus, Smad10 chick and spinal cord formation in the frog (Cox and
seems to be required for heart and kidney formation. Hemmati-Brivanlou, 1995; Holowacz and Sokol, 1999;
The necessity of Smad10 for multiple organizer- Kengaku and Okamato, 1995; Lamb and Harland, 1995;
dependent activities raised the possibility that Smad10 Ribisi et al., 2000; Streit et al., 2000). As Smad10 is
might be required for formation of the organizer. How- necessary for formation of neural structures, including
ever, in situ hybridization (Figures 4C) and RT-PCR (Fig- the spinal cord (Figures 2 and 3), it followed that FGF
ure 4D) results showed that Smad10 MO had no effect might require Smad10 for its neuralizing properties. To
on expression of the organizer-specific markers noggin test this notion, we injected embryos with control MO,
and goosecoid, or a more general mesodermal marker, Smad10 MO, DNS10 mRNA, or -galactosidase mRNA
brachyury. Likewise, the formation of the dorsal blasto-
and explanted animal caps. During gastrulation, we cul-
pore lip, the site of organizer invagination (Harland and
tured the caps in the presence of FGF under conditionsGerhart, 1997), appeared temporally and spatially nor-
that induce formation of neural tissue (Lamb and Har-mal in S10 MO embryos (Figures 4C and 4E). In addition,
land, 1995) and then analyzed the caps for expressionin situ hybridization (Figure 4E) and RT-PCR (Figure 4F)
of neural markers. In situ hybridizations showed thatshowed no effect of the S10 MO on the expression
FGF induced expression of the spinal cord markerof markers of anterior/pharyngeal endoderm, Xhex and
HoxB9 in uninjected animal caps and in animal capsCerberus (Zorn et al., 1999), or markers of general endo-
injected with control morpholino or -galactosidasederm, Xsox17 (Hudson et al., 1997) and endodermin.
mRNA (Figures 5A and 5B). Of note, both Smad10 MO
and DNS10 blocked induction of HoxB9 by FGF (FiguresNeural Induction by FGF Requires Smad10
5A and 5B). These results were confirmed by RT-PCRTwo separate classes of organizer-derived secreted
molecules—FGFs and BMP antagonists—are thought analysis (Figure 5C). FGF, when added during blastula
Smad10 Is Required for Nervous System Formation
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Figure 4. Smad10 Is Required for Formation of Organizer-Induced Tissues
(A) Embryos were injected and analyzed by in situ hybridization as in Figure 2B. H, heart.
(B) Two-cell embryos were injected with 5 ng morpholino into both animal poles and analyzed by RT-PCR at stage 33. WT-1 marks the kidney;
NKX2.5 marks the heart.
(C and D) Both animal poles of two-cell embryos were injected with morpholino and at stage 10.25 the embryos were processed for in situ
hybridizations (C) or RT-PCR (D). GC, goosecoid; BU, brachyury.
(E and F) Embryos were injected as in (C) and analyzed by in situ hybridization (E) with probes for XHex (stage 10.25) and endodermin (EDD,
stage 27) or analyzed by RT-PCR (F) for the endodermal markers XHex (stage 10.25), Cerberus (cerb, stage 10.25), Xsox17 (both  and 
isoforms, stage 10.25), and EDD (stage 27).
stages, induces formation of mesoderm (Lamb and Har- Neural Induction by Noggin Requires Smad10
Many of the secreted neural inducers identified throughland, 1995). Decreasing Smad10 activity did not alter
the FGF-dependent induction of mesoderm, while XFD gain-of-function studies act by inhibiting BMP signaling
(Harland and Gerhart, 1997; Sasai and De Robertis,(Amaya et al., 1991), the dominant-negative FGF recep-
tor, did (Figure 5D). Thus, Smad10 does not block all FGF 1997). Unlike the FGFs, BMP antagonists induce anterior
neural tissue. As Smad10 is necessary for anterior asactivities, but rather is required specifically for neural
induction by FGF. well as posterior neural development, we tested the idea
Developmental Cell
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Figure 5. Smad10 Is Required for FGF-Mediated Neural Induction
(A) One-cell embryos were uninjected or injected with Smad10 or control MO and then animal caps were treated with FGF protein at the
gastrula stage. These caps, and uninjected/untreated caps (Control), were analyzed at stage 27 by whole-mount in situ hybridization.
(B) -gal-injected, -gal-injected/FGF-treated (FGF  -gal), and DNS10-injected/FGF-treated animal caps were analyzed by whole-mount in
situ hybridization.
(C) Animal caps treated as in (A) and (B) were analyzed by RT-PCR.
(D) Uninjected, dominant-negative FGF receptor-injected (XFD, 1 ng), and DNS10-injected animal caps were cultured during the blastula stage
in the absence or presence of FGF. These caps were then analyzed by RT-PCR at stage 11.
that Smad10 might be required for neural induction by PX(S/T)P Erk phosphorylation sites within its linker re-
gion, which raised the possibility that Smad10 activitynoggin, a prototypical BMP antagonist. To that end, we
might be influenced by a receptor tyrosine kinase path-injected noggin mRNA alone, with Smad10 MO, or with
way (Hill and Treisman, 1995). To test the biological con-control MO, and evaluated the expression of neural
sequences of such potential phosphorylation, we gener-markers. As assessed by in situ hybridization, noggin
ated a Smad10 construct, Smad10-PXAPx3, that encodedinduced the expression of NRP-1 (Figure 6A). This ex-
alanine substitutions at each of the three PX(S/T)P phos-pression was not altered by control MOs (Figure 6A). In
phorylation sites in Smad10. Then, we injected animalcontrast, Smad10 MO blocked noggin-dependent neu-
caps with mRNAs encoding wild-type Smad10 andral induction (Figure 6A). These results were confirmed
Smad10-PXAPx3 and analyzed neural induction. Bothby RT-PCR analysis (Figure 6B). Thus, Smad10 activity
the wild-type and the PXAPx3 mutant induced the ex-is necessary for noggin-mediated neural induction.
pression of NCAM and otx2 (anterior neural; Figure 7A).
Although the wild-type Smad10 induced the expression
Smad10 Contains ERK Consensus Phosphorylation of the spinal cord marker HoxB9, the PXAPx3 mutant
Sites, which Are Required for Posterior Neuralization did not (Figure 7A). One possible explanation for the
Smads are central components of TGF superfamily lack of HoxB9 expression was that the mutations altered
signaling and Smads are phosphorylated by TGF ser- the stability of Smad10. However, the wild-type and
ine/threonine kinase receptors at their carboxy-terminal PXAPx3 Smad10 protein levels appeared equal at sev-
domain; this phosphorylation is thought to activate eral different stages (not shown). Of note, another form
Smads and control their biological function (Derynck of Smad10 in which the PX(S/T)P Erk phosphorylation
and Zhang, 1996; Heldin et al., 1997; Hill, 1999; Mas- sites were mutated to acidic residues activated expres-
sague, 1996; Piek et al., 1999; Wrana and Attisano, 1996; sion of HoxB9, as well as otx2, like wild-type Smad10.
Zhang et al., 1996). Erk kinases also phosphorylate Although several explanations exist for the loss of
Smads, but in their linker region. This phosphorylation spinal cord formation detected when the PX(S/T)P sites
alters the subcellular localization of Smads and often were mutated, a parsimonious possibility is that an Erk-
abolishes their activity, although one report suggested dependent phosphorylation of Smad10 was abolished.
the opposite (de Caestecker et al., 1998; Kretzschmar To explore this option, we performed in vitro phosphory-
lation assays with recombinant forms of Smad10 andet al., 1997, 1999). Smad10 contains three canonical
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Figure 6. Smad10 Is Required for Noggin-Mediated Neural Induction
(A) One-cell embryos were injected with noggin mRNA (Nog, 250 pg) alone, with Smad10 MO, or with control MO. Animal caps from these
as well as uninjected embryos (control) were explanted, cultured, and analyzed by whole-mount in situ hybridization.
(B) Animal caps treated identically to those described in (A) were processed for RT-PCR analysis.
activated Erk2 proteins and found that Erk2 directly and that the PX(S/T)P consensus phosphorylation sites
on Smad10 are required for this Erk-dependent phos-phosphorylated Smad10 (Figure 7B). In addition, in vitro
phosphorylation assays confirmed that the PXAPx3 mu- phorylation. Of note, when the Erk consensus sites are
mutated to alanine, Smad10 remains functional and gen-tations diminished Erk phosphorylation of Smad10 (Fig-
ure 7C). Thus, phosphorylation of Smad10 at the PX(S/T)P erates anterior neural fates; however, the mutant no
sites might be critical for formation of the spinal cord. longer produces posterior neural fates. This suggests
that the nonphosphorylated and phosphorylated forms
of Smad10 might interact with different subsets of tran-Discussion
scription factors to generate distinct cell fates. Erks of-
ten phosphorylate and activate transcription factors thatSmad10 must be present and able to act for the Xenopus
regulate gene expression (Blenis, 1993; Egan et al., 1993;nervous system to form. A full range of anterior-posterior
Hill and Treisman, 1995). Smad10 may be another exam-neural markers, as well as a neural crest derivative, was
ple of such a transcription factor. Taken together, theselost when Smad10 function was diminished. The obser-
data suggest that an RTK signal, rather than a TGFvation that Smad10 is required for the neuralizing activity
signal, might control Smad10’s biological function inof two important classes of secreted factors (BMP an-
anterior versus posterior neural development.tagonists and FGF) further suggests that Smad10 might
If Smad10 transduces an RTK signal, what ligandact as a key component in the formation of both anterior
might activate the cascade? One plausible candidateand posterior neural tissue. Since Smad10 is also re-
is FGF. FGFs signal via an RTK pathway that involvesquired for expression of heart and kidney markers, and
phosphorylation and activation of Erks (Ribisi et al.,formation of these tissues requires organizer activity,
2000; Umbhauer et al., 1995). This FGF pathway hasthese results raise the possibility that Smad10 might
similar biological functions to Smad10; both induce pos-be a mediator of several organizer-derived functions.
terior neural fates. Furthermore, FGF requires Smad10However, the defects in cardiogenesis and nephrogen-
for this activity. These data, coupled with the in vitroesis observed when Smad10 activity was reduced might
phosphorylation results and the inability of the Smad10-also be secondary to Smad10 functions that are not
PXAPx3 mutant to induce spinal cord formation, arerelated to the organizer.
consistent with the idea that FGF initiates an RTK path-Like many signal transduction cascades, TGF signal-
way that leads to activation of Erk, subsequent phos-ing is subject to crosstalk regulation by other pathways.
phorylation of Smad10, and induction of posterior neuralFor example, the receptor tyrosine kinase (RTK) cascade
fates. Additional biochemical experiments will be re-can modify TGF signaling, presumably via Erk-depen-
quired to test this hypothesis.dent phosphorylation of Smads (de Caestecker et al.,
Smad10 is most similar in primary structure to the co-1998; Kretzschmar et al., 1997, 1999; Piek et al., 1999).
Smad, Smad4, that associates with R-Smads once theTypically, this phosphorylation inhibits Smad function
R-Smads are phosphorylated by the ligand-activatedby excluding them from the nucleus (Kretzschmar et al.,
receptor complex. Both Hill’s and Nishida’s groups have1999). That is, RTK signaling decreases the amplitude
presented biochemical evidence that Smad10 can actof the TGF signal but does not alter its quality. Our
as a co-Smad and termed Smad10 as Smad4, to high-data suggest an extension of this idea and imply that
light the similarities with Smad4 (Howell et al., 1999;an RTK pathway may regulate the function of Smad10
Masuyama et al., 1999). The data presented here areand may do so in a direct biochemical sense. We find
consistent with the idea that Smad10 could be a co-that Smad10 contains Erk consensus phosphorylation
sites, that Erk2 directly phosphorylates Smad10 in vitro, Smad, although our studies do not directly address this
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Smad3 (90% identity) have a much higher degree of
structural conservation. Furthermore, Smad10 and Smad4
have cell biological and biochemical differences, and
they display distinct activities in both Xenopus embryos
and tissue culture cells. These differences support a
model in which the two potential co-Smads, 4 and 10,
might induce distinct transcriptional responses, even
when bound to the identical R-Smad (Howell et al., 1999;
Masuyama et al., 1999). These functional differences
may, in part, be accounted for by differences in primary
structure, which presumably alters the panoply of tran-
scription factors with which the Smads interact. For
example, Smad4 induces mesoderm and binds with
FAST-1, a transcription factor that is necessary and suf-
ficient for mesoderm formation. In contrast, Smad10 is
necessary and sufficient for neural tissue formation and
interacts with the neuralizing transcription factor Hesr-1.
Both Hill and Nishida suggested that Smad10 func-
tions in mesoderm formation or patterning (Howell et al.,
1999; Masuyama et al., 1999). Although these activities
appear distinct from those we have described, the ob-
servations were made with different experimental condi-
tions, which may explain the different outcomes. The
loss-of-function data presented here support the idea
that Smad10 plays a key role in formation of the nervous
system and not one in mesoderm induction. Our experi-
ments do not eliminate the possibility that Smad10 also
plays a role in mesoderm formation; we targeted the
microinjections to neural, and not mesodermal, precur-
sors. In addition, we did not examine ventralization, so
we have no data in that regard. Another potential source
of complication is the high maternal level of Smad10
mRNA; so, maternal Smad10 protein might also be pres-
ent. The morpholinos block translation of the Smad10
message and would not affect the maternally contrib-
uted Smad10 protein, potentially only decreasing Smad10
protein levels gradually. So early events, such as meso-
derm induction, might not be affected, while later pro-
cesses—neural induction, heart formation, and nephro-
genesis—might be significantly altered. The protein
inhibitory form of Smad10, DNS10, might overcome this
possible limitation. The DNS10 embryos had dramatic
perturbations in nervous system formation but meso-
derm induction proceeded. However, the DNS10 is less
potent than the Smad10 morpholino and might not be
able to inhibit mesoderm formation. Another alternative
is that Smad4 and Smad10 play redundant roles in
Figure 7. Erk-Mediated Signaling May Regulate Smad10 Activity mesoderm, but not neural, induction. Further studies,
(A) Uninjected, Smad10-injected, and Smad10-PXAPx3-injected an- such as with Smad4 morpholinos, should clarify this
imal caps were analyzed by RT-PCR. issue.
(B) Purified recombinant GST or GST-Smad10 protein was incubated
The current data indicate that Smad10 is necessarywith purified and activated Erk2 in the presence of [32P]ATP and
for formation of the frog nervous system and is requiredanalyzed with SDS-PAGE and autoradiography.
by BMP antagonists and FGF signals for neural in-(C) Recombinant purified His-tag-Smad10 and His-tag-Smad10-
PXAPx3 (S10PXAPx3) were tested for phosphorylation by activated duction. Many aspects of the molecular mechanisms
Erk in vitro as described in (B). Protein loading was determined by that control neural development are conserved between
Coomassie (Co) staining. vertebrates. BMP antagonists and FGF signaling are
thought important in neural formation in frogs, chicks,
and mice. Given the requirement of Smad10 in frogs for
issue. Many observations suggest that individual poten- neural induction by either the BMP inhibitors or FGF
tial R-Smad complexes, with either Smad4 or Smad10, and their role in other vertebrates, Smad10 might also
might produce different functional consequences. This be conserved. However, no Smad10 ortholog has yet
possibility is supported by the relatively low identity, for been identified in chicks or mice. It is possible that
Smads, between Smad4 and Smad10 (65%). Smad1, Smad10’s role is unique to frogs or that this function
has been subsumed by other transcription factors suchSmad5, and Smad8 (80%–90% identity) or Smad2 and
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